CV Sciences (CVSI) Interest Coverage Ratio Growth (3y) (2015 - 2026)
CV Sciences (CVSI) Interest Coverage Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 41.72% |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn | -29.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.62% |
| Mar 31, 2025 | 26.60% |
| Dec 31, 2024 | -141.35% |
| Sep 30, 2024 | 62.98% |
| Jun 30, 2024 | 35.13% |
| Mar 31, 2024 | -34.22% |
| Sep 30, 2023 | -45.44% |
| Jun 30, 2023 | -67.08% |
| Mar 31, 2023 | 134.17% |
| Mar 31, 2022 | -229.53% |
| Dec 31, 2021 | -26.00% |
| Sep 30, 2021 | -1,042.28% |
| Jun 30, 2021 | -324.19% |
| Mar 31, 2021 | -100.19% |
| Sep 30, 2020 | 48.46% |
| Jun 30, 2020 | 12.40% |
| Mar 31, 2020 | 60.11% |
| Sep 30, 2019 | 77.09% |
| Jun 30, 2019 | 26.02% |
| Mar 31, 2019 | 72.50% |